[go: up one dir, main page]

WO2007110871A3 - Procedes et composition pour le traitement des maux de gorge - Google Patents

Procedes et composition pour le traitement des maux de gorge Download PDF

Info

Publication number
WO2007110871A3
WO2007110871A3 PCT/IL2007/000412 IL2007000412W WO2007110871A3 WO 2007110871 A3 WO2007110871 A3 WO 2007110871A3 IL 2007000412 W IL2007000412 W IL 2007000412W WO 2007110871 A3 WO2007110871 A3 WO 2007110871A3
Authority
WO
WIPO (PCT)
Prior art keywords
throat
composition
sore throat
methods
severity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2007/000412
Other languages
English (en)
Other versions
WO2007110871A2 (fr
Inventor
Eran Eilat
Nitsan Primor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAVEH PHARMA (1996) Ltd
NAVEH PHARMA 1996 Ltd
Original Assignee
NAVEH PHARMA (1996) Ltd
NAVEH PHARMA 1996 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAVEH PHARMA (1996) Ltd, NAVEH PHARMA 1996 Ltd filed Critical NAVEH PHARMA (1996) Ltd
Priority to EP07736152A priority Critical patent/EP2015761A4/fr
Publication of WO2007110871A2 publication Critical patent/WO2007110871A2/fr
Publication of WO2007110871A3 publication Critical patent/WO2007110871A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un procédé destiné à traiter, calmer ou réduire la sévérité d'un mal de gorge ou d'autres irritations de la gorge pendant une durée prolongée, spécialement pendant le sommeil, par l'administration d'une composition pharmaceutique à l'arrière de la gorge. La composition comprend un véhicule huileux qui crée un enrobage huileux sur la gorge d'un sujet et une matière active dans une quantité efficace pour traiter, calmer ou réduire la sévérité d'un mal de gorge. La composition est administrée de préférence sous la forme d'une pulvérisation pour la gorge et elle soulage le mal de gorge pendant une durée prolongée, de préférence pendant toute la nuit.
PCT/IL2007/000412 2006-03-29 2007-03-29 Procedes et composition pour le traitement des maux de gorge Ceased WO2007110871A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07736152A EP2015761A4 (fr) 2006-03-29 2007-03-29 Procedes et composition pour le traitement des maux de gorge

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78680906P 2006-03-29 2006-03-29
US60/786,809 2006-03-29

Publications (2)

Publication Number Publication Date
WO2007110871A2 WO2007110871A2 (fr) 2007-10-04
WO2007110871A3 true WO2007110871A3 (fr) 2007-12-06

Family

ID=38541536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2007/000412 Ceased WO2007110871A2 (fr) 2006-03-29 2007-03-29 Procedes et composition pour le traitement des maux de gorge

Country Status (2)

Country Link
EP (1) EP2015761A4 (fr)
WO (1) WO2007110871A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2453770A (en) 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
GB0722349D0 (en) * 2007-11-15 2007-12-27 Reckitt Benckiser Healthcare Use of anti-bacterial compounds having an anaesthetic effect
MX344359B (es) * 2008-08-22 2016-12-14 Reckitt Benckiser Healthcare (Uk) Ltd Composición particulada ingerible para el dolor de garganta.
PL2344329T3 (pl) 2008-10-02 2013-05-31 Mylan Inc Sposób wytwarzania wielowarstwowego laminatu przylepnego
GB201013183D0 (en) * 2010-08-05 2010-09-22 Aesica Pharmaceuticals Ltd Efficient and cost-effective process for the manufacture of amyl m-cresol
RS61753B1 (sr) 2011-04-29 2021-05-31 Moberg Pharma Ab Farmaceutske kompozicije koje sadrže lokalni anestetik kao što je bupivakain za lokalno administriranje u usta ili grlo
DE202013000446U1 (de) * 2012-10-04 2013-10-07 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung, insbesondere pharmazeutische Zusammensetzung, insbesondere zur Verabreichung bei Heiserkeit und Halsschmerzen
WO2016108233A1 (fr) * 2014-12-30 2016-07-07 Erez Zabari Formulation topique pour le traitement cosmétique de la peau et des cheveux
GB201507279D0 (en) * 2015-04-29 2015-06-10 Brien Sean L O Odontalgic preparation
CA3045118A1 (fr) 2016-11-28 2018-05-31 Johnson & Johnson Consumer Inc. Compositions liquides comprenant un agent mucoadhesif
BE1028842B1 (fr) * 2020-12-02 2022-07-05 Orionis Composition d'huiles essentielles
TR2021021888A2 (tr) * 2021-12-30 2022-01-21 Bezmialem Vakif Ueniversitesi Anti̇vi̇ral etki̇li̇ bi̇r bi̇tki̇sel kompozi̇syon ve bunun üreti̇m yöntemi̇
CN116531328A (zh) * 2023-05-11 2023-08-04 湖北凤凰白云山药业有限公司 一种聚维酮碘菊花喷雾剂的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113887A (en) * 1992-12-21 2000-09-05 Sunstar Kabushiki Kaisha Toothpaste composition
US6315987B1 (en) * 2000-05-10 2001-11-13 Isp Investments Inc. Polymeric delivery and release systems for oral care actives
US6379652B1 (en) * 2000-10-16 2002-04-30 Colgate Palmolive Company Oral compositions for reducing mouth odors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2333450A (en) * 1998-01-23 1999-07-28 Marshtech International Ltd Anti-Snoring Compositions
ATE525061T1 (de) * 2001-02-28 2011-10-15 Axiomedic Ltd Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
FR2860720A1 (fr) * 2003-10-09 2005-04-15 Jean Pascal Conduzorgues Nouvelles compositions pharmaceutiques pour traiter la xerostomie et maladies similaires
DE202004016078U1 (de) * 2004-09-22 2005-11-10 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Schleimdrogenbasierte Lutschtablette gegen entzündliche Erkrankungen des Mund- und Rachenraums

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113887A (en) * 1992-12-21 2000-09-05 Sunstar Kabushiki Kaisha Toothpaste composition
US6315987B1 (en) * 2000-05-10 2001-11-13 Isp Investments Inc. Polymeric delivery and release systems for oral care actives
US6379652B1 (en) * 2000-10-16 2002-04-30 Colgate Palmolive Company Oral compositions for reducing mouth odors

Also Published As

Publication number Publication date
EP2015761A4 (fr) 2009-07-29
EP2015761A2 (fr) 2009-01-21
WO2007110871A2 (fr) 2007-10-04

Similar Documents

Publication Publication Date Title
WO2007110871A3 (fr) Procedes et composition pour le traitement des maux de gorge
WO2011014255A8 (fr) Traitement de la maladie de crohn au moyen de laquinimod
WO2009149369A3 (fr) Compositions de traitement de l’acné comportant une nanoparticule d’argent et utilisations
WO2006039704A3 (fr) Composition pharmaceutique et methode de traitement d'une arthropathie a capsule articulaire
WO2007100675A3 (fr) Procédé de traitement de la cellulite
WO2011107755A3 (fr) Administration immédiate / retardée de médicament
WO2004103297A3 (fr) Polytherapie a base d'acetate de glatiramer et de mitoxantrone destinee au traitement de la sclerose en plaques
WO2009109618A3 (fr) Nouveaux dérivés de 1-benzyl-3-hydroxyméthylindazole et leur utilisation dans le traitement des maladies basées sur l’expression de mcp-1, cx3cr1 et p40
WO2009090624A3 (fr) Gel de chitosane pour applications dermatologiques, procédé d'obtention et d'utilisation de celui-ci
WO2009028495A1 (fr) Agent pour une dermatite fongique
WO2006029036A3 (fr) Therapie combinee avec du glatiramere acetate et de la n-acetylcysteine pour traiter la sclerose en plaques
IL219857A0 (en) Mitotic kinesin inhibitors, pharmaceutical compositions comprising them, uses thereof in the manufacture of a medicament for the treatment of disease or disorder in a human or animal that can be treated by inhibiting mitosis
WO2010030180A3 (fr) Formulations de peptides et leurs utilisations
WO2007138466A3 (fr) Compositions pharmaceutiques comprenant une combinaison de meloxicam et de tramadol
WO2009104080A3 (fr) Compositions pharmaceutiques actives sur le snc et méthodes d'utilisation
NZ610925A (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
WO2009109616A3 (fr) Nouveaux dérivés de 1-benzyl-3-hydroxyméthylindazole et leur utilisation dans le traitement des maladies basées sur l'expression de mcp-1, cx3cr1 et p40
WO2006098603A3 (fr) Composition renfermant de l'isoorientine pour suppression d'histamine
WO2004110380A3 (fr) Traitement des maladies a mediation immunologique au moyen de composes a base de vitamine d active, seuls ou en association avec d'autres agents therapeutiques
WO2009109654A8 (fr) Nouveaux dérivés de 1-benzyl-3-hydroxyméthylindazole et leur utilisation dans le traitement des maladies basées sur l’expression de mcp-1 et cx3cr1
WO2010090494A3 (fr) Utilisation médicale de dérivés d'acide 5-benzylaminosalicylique ou de sels correspondants
WO2007120485A3 (fr) Procédés de traitement de la douleur avec des alkylxanthines et des antiépileptiques et compositions à utiliser à cet effet
WO2008012796A3 (fr) Compositions pharmaceutiques comprenant ccl2 et leur utilisation dans le traitement d'une inflammation
WO2008070010A3 (fr) Rétablissement après une attaque
WO2011024168A3 (fr) Systèmes de délivrance à libération prolongée pour la prévention et le traitement de cancers de la tête et du cou

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07736152

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007736152

Country of ref document: EP